Item 8.01 Other Events.
On January 25, 2022, Mitchell Finer, Ph.D. and Oncorus, Inc. (the "Company")
agreed that, effective as of such date, Dr. Finer will transition from his
current role as Executive Chairman to non-executive Chairman of the Company's
board of directors. In connection with this transition, Dr. Finer and the
Company agreed to terminate the Employment Agreement dated as of August 8, 2018,
as amended on each of November 14, 2018 and April 6, 2020, by and between Dr.
Finer and the Company (the "Employment Agreement"). There were no disagreements
between the Company and Dr. Finer giving rise to this transition or the decision
to terminate the Employment Agreement. Following the termination of the
Employment Agreement, Dr. Finer will be entitled to compensation for his role as
Chairman of the board of directors in accordance with the Company's non-employee
director compensation policy, as currently in effect. In addition, neither Dr.
Finer's transition to non-executive Chairman nor the termination of the
Employment Agreement will affect his outstanding equity awards with the Company,
or otherwise be deemed an interruption of Dr. Finer's continuous service for the
purpose of the awards previously granted to him under the Company's equity
incentive plans.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
ONCORUS, INC. 
